Clinical Trials on Specific Phobia

Total 1822 results

City of Hope Medical Center
National Cancer Institute (NCI)

Completed

High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Surrey

Completed

Selenium in the Prevention of Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
National Cancer Institute (NCI)

Completed

Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

KRN5500 in Treating Patients With Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Terminated

Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials

Unspecified Adult Solid Tumor, Protocol Specific

United States
SRI International
National Cancer Institute (NCI)

Completed

Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Josephine Ford Cancer Center
National Cancer Institute (NCI)

Unknown

Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations

Unspecified Adult Solid Tumor, Protocol Specific

United States
Montclair State University
National Cancer Institute (NCI)

Unknown

Promoting Physical Activity In After-School Programs for Urban Adolescents

Unspecified Adult Solid Tumor, Protocol Specific

United States
Brown University
National Cancer Institute (NCI)

Unknown

Personalized Nutrition Education in Improving Eating Habits of Healthy Participants Who Eat an Unhealthy Diet

Unspecified Adult Solid Tumor, Protocol Specific

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Health Education in Improving the Understanding of Medical Information

Unspecified Adult Solid Tumor, Protocol Specific
Children's Cancer and Leukaemia Group

Unknown

Pharmacokinetics of Dactinomycin in Young Patients With Cancer

Unspecified Childhood Solid Tumor, Protocol Specific

Ireland, United Kingdom
Vion Pharmaceuticals

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Lombardi Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals

Completed

VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
Brown University
National Cancer Institute (NCI)

Completed

Nutrition Education for Low-Income Healthy Participants Who Eat an Unhealthy Diet

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute

Completed

Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
NYU Langone Health
National Cancer Institute (NCI)

Completed

Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Interleukin-7 in Treating Patients With Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

A New Radiation Therapy Planning System in Patients Undergoing Radiation Therapy for Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Computed Tomography in Detecting Movement of the Esophagus in Patients Undergoing Radiation Therapy to the Chest

Unspecified Adult Solid Tumor, Protocol Specific

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Yale University
National Cancer Institute (NCI)

Completed

Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
San Antonio Cancer Institute

Completed

BMS-184476 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Kansas
National Cancer Institute (NCI)

Completed

Indole-3-Carbinol in Preventing Cancer in Healthy Participants

Unspecified Adult Solid Tumor, Protocol Specific

United States
Stanford University

Recruiting

Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute
Cleveland BioLabs, Inc.

Completed

Entolimod in Treating Patients With Locally Advanced or Metastatic Solid Tumors That Cannot Be Removed By Surgery

Unspecified Adult Solid Tumor, Protocol Specific

United States
Yale University
National Cancer Institute (NCI)

Completed

Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Pharmacokinetics of Daunorubicin in Young Patients With Cancer

Unspecified Childhood Solid Tumor, Protocol Specific

United States, Australia, Canada, Switzerland
NCIC Clinical Trials Group

Completed

MG98 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States, Canada
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Endostatin in Treating Patients With Advanced Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Genzyme, a Sanofi Company

Completed

SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Genzyme, a Sanofi Company

Completed

Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada, United States

Clinical Trials on Specific Phobia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations